Johnson & Johnson files for new Zytiga approval
11:36 EDT 15 Jun 2012 | Advantage Business Media
Johnson & Johnson said Friday it has asked U.S. and European Union regulators to grant broader marketing approval for its cancer pill Zytiga.Zytiga was approved in 2011 for the treatment of advanced prostate cancer in men who have received chemother..
Original Article: Johnson & Johnson files for new Zytiga approval
More From BioPortfolio on "Johnson & Johnson files for new Zytiga approval"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
